ESACT-UK 20th Annual Scientific Meeting Programme (version 2)

Wednesday 6th January 2010

9.30Registration desk opens

10.30-10.35ESACT-UK meeting introduction

10.35-12.00Session 1- Cell Culture Biotechnology

(Sponsored by BD)

Chair: Nick Amiss

10.35-11.15Keynote speaker – Animal Cell Culture Technology over the last 20 years

Ian Freshney, Honorary Senior Research Fellow in the Centre for Oncology & Applied Pharmacology, Division of Cancer Sciences and Molecular Pathology, Glasgow University

11.15-11.55Keynote speaker - State of the bioprocessing industry in the UK

Mark Bustard, bioProcessUK

11.55-12.30Keynote speaker – Therapeutic protein production; past perspective and future prospects

John Birch, Lonza

12.30-13.30Lunch

13.30-16.00Session 2 – Fermentation Technology

Chair: Julian Hanak

13.30-14.00Mixing Issues in Animal Cell Culture Bioreactors; Possible Implications for Stem Cell Culture

Alvin Nienow, University of Birmingham

14.00-14.30 Cell culture in miniature bioreactors: Engineering characterisation, scale-up and impact on primary recovery

Gary Lye, University College London

14.30-15.00Study of Alternating Tangential Flow filtration for perfusion and harvest in Chinese Hamster Ovary cells cultivation

Veronique Chotteau, Stockholm University

New Fermentation Technology From The Trade

15.00-15.15New Automated Cell Culture System: 6 parallel fed batch cultures with live cell imaging

Sharon Brownlow, Applikon Biotechnology

15.15-15.30High Throughput Process Development Technologies: Successful Implementation and Application to Process Improvement

JonathanH. Dempsey, Invitrogen

15.30-15.45The Development of a Single-Use 3L Bench-top Stirred-tank Bioreactor

Guy Matthews, Millipore

15.45-16.00Utilization of Cyclonic Technology for Re-Usable and Disposable Perfusion Bioreactors

John Moys, Sartorius Stedim

16.00-16.30 Tea/coffee, trade stands and poster viewing

16.30-18.00Session 3 –Student Session

Chair: Julian Hanak

16.30-16.45Improving CHO cell Productivity. The Pursuit of Happiness

Laura Bailey, University of Manchester

16.45-17.00The process of N-glycosylation in CHO cells can be manipulated for the production of desirable monoclonal antibody glycoforms

Rhian Grainger, University of Sheffield

17.00-17.15Molecular painting by numbers: Looking at CHO cell chromosomes

Leo Choi, University of Manchester

17.15-17.30A Comparison of Alternative Host CHO Cell Lines

Zoe Towler, University of Kent

17.30-18.00Poster flashes

Rational feed design based on metabolite profiling of mammalian cell lines

Arfa Maqsood, University of Manchester

Use of SIFT-MS for the on-line monitoring of stem cell production in stirred-tank bioreactors

Tom Chippendale, Keele University

A systematic examination of phenotypic heterogeneity in CHO cells

Clare Lovelady, University of Sheffield

Automation of human embryonic stem cell culture

Gayatri Ramasamy, Loughborough University

Enhancing recombinant mRNA translation via microRNA interactions with the 3'-UTR for improved recombinant protein yield

Elizabeth Sayer, University of Kent

Developing scalable and standardised manufacturing methods for human mesenchymal stem cells

Qasim Rafiq, Loughborough University

18.00-18.15ESACT-UK Annual General Meeting

18.15-19.30 Posters, trade stands and networking

A coach will be provided for transportation between Holywell and Burleigh Court at 19.30

20.00ESACT-UK society dinner and after-dinner quiz

Thursday 7th January 2010

7.30-8.45Breakfast

A coach will be provided for transportation between Burleigh Court and Holywell at 8.45

9.10-10.10Session 4 - Developments in Antibody and Therapeutic Protein Bioprocessing

Chair: John Davis

9.10-9.40Determination of Post-Transcriptional Limitations on Recombinant Antibody Production

Emma Mead, University of Kent

9.40-10.10Practical challenge and innovative solution: natural consummation or enforced annulment in therapeutic bioprocessing?

Andy Lyddiatt, Lyddallan Consultancy

10.10-11.00Tea/coffee, trade stands and poster viewing

11.00-13.10Session 5 – Regenerative Medicine Bioprocessing

(Sponsored by IChemE BESG)

Chair: Chris. J. Hewitt

11.00-11.10Introduction to regenerative medicine bioprocessing

Chris. J. Hewitt, Loughborough University

11.10-11.40The biochemical engineering challenges of embryonic stem cell processes

Farlan Veraitch, University College London

11.40-12.10Towards scale-up of tissue engineering systems by using an iterative approach to scaffold and bioreactor design

Marrianne Ellis, University of Bath

12.10-12.40In-vitro expansion of stem and progenitor cells

Mohamed Al-Rubeai, University College Dublin

12.40-13.10Automated manufacture of stem cells for regenerative medicine applications

Robert Thomas, Loughborough University

13.10-14.15Lunch

14.15-15.45Session 6 – Cell Based Bioactivity Testing

Chair: Joanna Long

14.15-14.45Cell-based alternatives: Getting to replacement

Nirmala Bhogal, FRAME, Nottingham

14.45-15.15Cell Culture Methods as Alternatives to Animal Testing – Advances and Challenges

Carol Barker, XCellR8 Ltd, Manchester

15.15-15.45Enabling and Delivering High Quality, Reproducible Cell-Based Assays; Impact of Frozen Cell Technology

Danuta Mossakowska, GlaxoSmithKline

15.45-16.15Award of prizes and close of meeting